Real-time enrollment status for this solid tumors clinical trial
Current Status
Terminated
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT04260256 |
| Recruiting Status | Terminated |
| Condition | Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 2 sites in the US |
| Sponsor | CellSight Technologies, Inc. |
| Last Updated on CT.gov | March 27, 2026 (3 weeks ago) |
As of April 17, 2026: Clinical trial NCT04260256 is currently terminated participants. This clinical trial study for solid tumors is not currently accepting new participants at 2 locations across the United States. The study is sponsored by CellSight Technologies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04260256 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04260256 was last updated 3 weeks ago (March 27, 2026). HelloStudys verifies this status automatically.